A Pilot Project of Virologic, Pharmacologic and Immunologic Correlates of Gastrointestinal-Associated Lymphoid Tissue Immune Reconstitution Following Maraviroc Therapy

NCT00870363 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

44

Enrollment

OTHER

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: maraviroc in combination with 2 NRTIs (dual nucleoside reverse transcriptase inhibitor)
DRUG: maraviroc plus raltegravir in combination with 2 NRTIs (dual nucleoside reverse transcriptase inhibitor)
DRUG: efavirenz [or other NNRTI (non-nucleoside reverse transcriptase inhibitor)]

Sponsor

University of California, Davis